(19)
(11) EP 4 815 913 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24821969.3

(22) Date of filing: 20.11.2024
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61L 15/38(2006.01)
A61L 26/00(2006.01)
 A61L 15/24(2006.01)
A61L 15/44(2006.01)
(52) Cooperative Patent Classification (CPC):
A61L 26/0014; A61L 26/0057; A61L 26/0066; A61L 15/24; A61L 15/38; A61L 15/44; A61L 2300/254; A61K 9/0014; A61K 47/10
 
C-Sets:
  1. A61L 26/0014, C08L 23/06;
  2. A61L 15/24, C08L 23/06;
(86) International application number:
PCT/IB2024/061619
(87) International publication number:
WO 2025/114817 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 30.11.2023 US 202363604638 P

(71) Applicant: Osiris Therapeutics, Inc.
Columbia, MD 21046 (US)

(72) Inventors:
  • JOVANOVIC, Aleksa
    MEMPHIS, Tennessee 38116 (US)
  • FREDERICK, Rosie
    MEMPHIS, Tennessee 38116 (US)

(74) Representative: Appleyard Lees IP LLP 
G Mill Dean Clough Industrial Park
Halifax HX3 5AH
Halifax HX3 5AH (GB)

   


(54) METHODS AND COMPOSITIONS FOR ENZYMATIC WOUND DEBRIDEMENT